A detailed history of Td Private Client Wealth LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 324 shares of BMRN stock, worth $21,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
324
Holding current value
$21,730
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $24,115 - $29,879
324 New
324 $26.7 Million
Q1 2024

Aug 16, 2024

BUY
$83.81 - $99.0 $9,051 - $10,692
108 Added 76.6%
249 $21.7 Million
Q4 2023

Aug 16, 2024

BUY
$76.22 - $98.51 $1,829 - $2,364
24 Added 20.51%
141 $13.6 Million
Q3 2023

Aug 16, 2024

BUY
$85.07 - $94.48 $935 - $1,039
11 Added 10.38%
117 $10.4 Million
Q2 2023

Aug 16, 2024

BUY
$86.68 - $100.3 $2,253 - $2,607
26 Added 32.5%
106 $9.19 Million
Q1 2023

Aug 16, 2024

BUY
$87.74 - $117.27 $1,228 - $1,641
14 Added 21.21%
80 $7.78 Million
Q4 2022

Aug 16, 2024

BUY
$80.93 - $108.63 $809 - $1,086
10 Added 17.86%
66 $6.83 Million
Q1 2022

Aug 16, 2024

SELL
$74.28 - $92.69 $1,039 - $1,297
-14 Reduced 20.0%
56 $4.32 Million
Q4 2021

Aug 16, 2024

BUY
$71.72 - $91.47 $2,151 - $2,744
30 Added 75.0%
70 $6.19 Million
Q3 2021

Aug 16, 2024

SELL
$74.77 - $85.47 $21,234 - $24,273
-284 Reduced 87.65%
40 $3.09 Million
Q2 2021

Aug 16, 2024

BUY
$75.51 - $84.79 $830 - $932
11 Added 29.73%
48 $4.01 Million
Q1 2021

Aug 16, 2024

BUY
$74.73 - $90.69 $1,120 - $1,360
15 Added 68.18%
37 $2.79 Million
Q4 2020

Aug 16, 2024

BUY
$72.61 - $90.2 $290 - $360
4 Added 22.22%
22 $1.93 Million
Q3 2020

Aug 16, 2024

BUY
$71.87 - $131.03 $718 - $1,310
10 Added 125.0%
18 $1.37 Million
Q2 2020

Aug 16, 2024

SELL
$79.55 - $124.22 $2,147 - $3,353
-27 Reduced 77.14%
8 $987,000
Q4 2019

Aug 16, 2024

SELL
$64.27 - $86.37 $18,574 - $24,960
-289 Reduced 89.2%
35 $2.96 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.